Moderna | MRNA - Net Income


Moderna reported $-1.34B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Acadia Pharmaceuticals USD 3.64M 269.93M Mar/2026
Agios Pharmaceuticals USD -99.11M 8.93M Mar/2026
Alnylam Pharmaceuticals USD 205.99M 19.57M Mar/2026
Amgen USD 1.82B 486M Mar/2026
Arrowhead Research USD -132.73M 163.54M Mar/2026
Biogen USD 319.5M 368.4M Mar/2026
BioMarin Pharmaceutical USD 105.53M 152.1M Mar/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Gilead Sciences USD 2.02B 162M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Incyte USD 303.33M 4.05M Mar/2026
Ionis Pharmaceuticals USD -93M 136M Mar/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR -765K 4.89M Jun/2025
Pharma Mar EUR 1.53M 58.13M Mar/2026
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Qiagen NV USD 107.83M 22.21M Dec/2025
Regeneron Pharmaceuticals USD 727.2M 117.4M Mar/2026
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026
Sartorius EUR 56.2M 37M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025
Ultragenyx Pharmaceutical USD -185M 56M Mar/2026
United Therapeutics USD 274.9M 89.4M Mar/2026
Vertex Pharmaceuticals USD 1.03B 159.7M Mar/2026
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026